Report Detail
Global Treatment-Resistant Hypertension Management Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4526868 |
- 03 April, 2023 |
- Global |
- 89 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Treatment-Resistant Hypertension Management market size was valued at USD 60 million in 2022 and is forecast to a readjusted size of USD 171.4 million by 2029 with a CAGR of 16.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The management of Treatment-Resistant Hypertension typically involves the use of multiple classes of antihypertensive medications, such as diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers (ARBs).
This report is a detailed and comprehensive analysis for global Treatment-Resistant Hypertension Management market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Treatment-Resistant Hypertension Management market size and forecasts, in consumption value ($ Million), 2018-2029
Global Treatment-Resistant Hypertension Management market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Treatment-Resistant Hypertension Management market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Treatment-Resistant Hypertension Management market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Treatment-Resistant Hypertension Management
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Treatment-Resistant Hypertension Management market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Janssen Biotech, Quantum Genomics, CinCor Pharma, Ionis Pharmaceuticals and Vifor Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Treatment-Resistant Hypertension Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Diuretic Therapy
Combination Therapy
Mineralocorticoid Receptor Antagonists
Market segment by Application
Hospital Pharmacy
Online Pharmacy
Retail Pharmacy
Market segment by players, this report covers
Janssen Biotech
Quantum Genomics
CinCor Pharma
Ionis Pharmaceuticals
Vifor Pharma
KBP Biosciences
Abbott
Kona Medical
Medtronic
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Treatment-Resistant Hypertension Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Treatment-Resistant Hypertension Management, with revenue, gross margin and global market share of Treatment-Resistant Hypertension Management from 2018 to 2023.
Chapter 3, the Treatment-Resistant Hypertension Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Treatment-Resistant Hypertension Management market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Treatment-Resistant Hypertension Management.
Chapter 13, to describe Treatment-Resistant Hypertension Management research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Treatment-Resistant Hypertension Management
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Treatment-Resistant Hypertension Management by Type
- 1.3.1 Overview: Global Treatment-Resistant Hypertension Management Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Treatment-Resistant Hypertension Management Consumption Value Market Share by Type in 2022
- 1.3.3 Diuretic Therapy
- 1.3.4 Combination Therapy
- 1.3.5 Mineralocorticoid Receptor Antagonists
- 1.4 Global Treatment-Resistant Hypertension Management Market by Application
- 1.4.1 Overview: Global Treatment-Resistant Hypertension Management Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital Pharmacy
- 1.4.3 Online Pharmacy
- 1.4.4 Retail Pharmacy
- 1.5 Global Treatment-Resistant Hypertension Management Market Size & Forecast
- 1.6 Global Treatment-Resistant Hypertension Management Market Size and Forecast by Region
- 1.6.1 Global Treatment-Resistant Hypertension Management Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Treatment-Resistant Hypertension Management Market Size by Region, (2018-2029)
- 1.6.3 North America Treatment-Resistant Hypertension Management Market Size and Prospect (2018-2029)
- 1.6.4 Europe Treatment-Resistant Hypertension Management Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Treatment-Resistant Hypertension Management Market Size and Prospect (2018-2029)
- 1.6.6 South America Treatment-Resistant Hypertension Management Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Treatment-Resistant Hypertension Management Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Janssen Biotech
- 2.1.1 Janssen Biotech Details
- 2.1.2 Janssen Biotech Major Business
- 2.1.3 Janssen Biotech Treatment-Resistant Hypertension Management Product and Solutions
- 2.1.4 Janssen Biotech Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Janssen Biotech Recent Developments and Future Plans
- 2.2 Quantum Genomics
- 2.2.1 Quantum Genomics Details
- 2.2.2 Quantum Genomics Major Business
- 2.2.3 Quantum Genomics Treatment-Resistant Hypertension Management Product and Solutions
- 2.2.4 Quantum Genomics Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Quantum Genomics Recent Developments and Future Plans
- 2.3 CinCor Pharma
- 2.3.1 CinCor Pharma Details
- 2.3.2 CinCor Pharma Major Business
- 2.3.3 CinCor Pharma Treatment-Resistant Hypertension Management Product and Solutions
- 2.3.4 CinCor Pharma Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 CinCor Pharma Recent Developments and Future Plans
- 2.4 Ionis Pharmaceuticals
- 2.4.1 Ionis Pharmaceuticals Details
- 2.4.2 Ionis Pharmaceuticals Major Business
- 2.4.3 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Product and Solutions
- 2.4.4 Ionis Pharmaceuticals Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Ionis Pharmaceuticals Recent Developments and Future Plans
- 2.5 Vifor Pharma
- 2.5.1 Vifor Pharma Details
- 2.5.2 Vifor Pharma Major Business
- 2.5.3 Vifor Pharma Treatment-Resistant Hypertension Management Product and Solutions
- 2.5.4 Vifor Pharma Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Vifor Pharma Recent Developments and Future Plans
- 2.6 KBP Biosciences
- 2.6.1 KBP Biosciences Details
- 2.6.2 KBP Biosciences Major Business
- 2.6.3 KBP Biosciences Treatment-Resistant Hypertension Management Product and Solutions
- 2.6.4 KBP Biosciences Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 KBP Biosciences Recent Developments and Future Plans
- 2.7 Abbott
- 2.7.1 Abbott Details
- 2.7.2 Abbott Major Business
- 2.7.3 Abbott Treatment-Resistant Hypertension Management Product and Solutions
- 2.7.4 Abbott Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Abbott Recent Developments and Future Plans
- 2.8 Kona Medical
- 2.8.1 Kona Medical Details
- 2.8.2 Kona Medical Major Business
- 2.8.3 Kona Medical Treatment-Resistant Hypertension Management Product and Solutions
- 2.8.4 Kona Medical Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Kona Medical Recent Developments and Future Plans
- 2.9 Medtronic
- 2.9.1 Medtronic Details
- 2.9.2 Medtronic Major Business
- 2.9.3 Medtronic Treatment-Resistant Hypertension Management Product and Solutions
- 2.9.4 Medtronic Treatment-Resistant Hypertension Management Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Medtronic Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Treatment-Resistant Hypertension Management Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Treatment-Resistant Hypertension Management by Company Revenue
- 3.2.2 Top 3 Treatment-Resistant Hypertension Management Players Market Share in 2022
- 3.2.3 Top 6 Treatment-Resistant Hypertension Management Players Market Share in 2022
- 3.3 Treatment-Resistant Hypertension Management Market: Overall Company Footprint Analysis
- 3.3.1 Treatment-Resistant Hypertension Management Market: Region Footprint
- 3.3.2 Treatment-Resistant Hypertension Management Market: Company Product Type Footprint
- 3.3.3 Treatment-Resistant Hypertension Management Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Treatment-Resistant Hypertension Management Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Treatment-Resistant Hypertension Management Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Treatment-Resistant Hypertension Management Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Treatment-Resistant Hypertension Management Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Treatment-Resistant Hypertension Management Consumption Value by Type (2018-2029)
- 6.2 North America Treatment-Resistant Hypertension Management Consumption Value by Application (2018-2029)
- 6.3 North America Treatment-Resistant Hypertension Management Market Size by Country
- 6.3.1 North America Treatment-Resistant Hypertension Management Consumption Value by Country (2018-2029)
- 6.3.2 United States Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 6.3.3 Canada Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Treatment-Resistant Hypertension Management Consumption Value by Type (2018-2029)
- 7.2 Europe Treatment-Resistant Hypertension Management Consumption Value by Application (2018-2029)
- 7.3 Europe Treatment-Resistant Hypertension Management Market Size by Country
- 7.3.1 Europe Treatment-Resistant Hypertension Management Consumption Value by Country (2018-2029)
- 7.3.2 Germany Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 7.3.3 France Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 7.3.5 Russia Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 7.3.6 Italy Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Treatment-Resistant Hypertension Management Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Treatment-Resistant Hypertension Management Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Treatment-Resistant Hypertension Management Market Size by Region
- 8.3.1 Asia-Pacific Treatment-Resistant Hypertension Management Consumption Value by Region (2018-2029)
- 8.3.2 China Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 8.3.3 Japan Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 8.3.5 India Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 8.3.7 Australia Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Treatment-Resistant Hypertension Management Consumption Value by Type (2018-2029)
- 9.2 South America Treatment-Resistant Hypertension Management Consumption Value by Application (2018-2029)
- 9.3 South America Treatment-Resistant Hypertension Management Market Size by Country
- 9.3.1 South America Treatment-Resistant Hypertension Management Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Treatment-Resistant Hypertension Management Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Treatment-Resistant Hypertension Management Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Treatment-Resistant Hypertension Management Market Size by Country
- 10.3.1 Middle East & Africa Treatment-Resistant Hypertension Management Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
- 10.3.4 UAE Treatment-Resistant Hypertension Management Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Treatment-Resistant Hypertension Management Market Drivers
- 11.2 Treatment-Resistant Hypertension Management Market Restraints
- 11.3 Treatment-Resistant Hypertension Management Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Treatment-Resistant Hypertension Management Industry Chain
- 12.2 Treatment-Resistant Hypertension Management Upstream Analysis
- 12.3 Treatment-Resistant Hypertension Management Midstream Analysis
- 12.4 Treatment-Resistant Hypertension Management Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Treatment-Resistant Hypertension Management . Industry analysis & Market Report on Treatment-Resistant Hypertension Management is a syndicated market report, published as Global Treatment-Resistant Hypertension Management Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Treatment-Resistant Hypertension Management market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
